Article info
PDFOriginal research
DNA methylation detection is a significant biomarker for screening endometrial cancer in premenopausal women with abnormal uterine bleeding
- Correspondence to Dr Dabao Xu, Gynecology, the Third Xiangya Hospital, Central South University, Changsha, Hunan, 410013, China; dabaoxu2022{at}163.com; Dr Weigang Lv, Gynecology, the Third Xiangya Hospital, Central South University, Changsha, Hunan, 410013, China; lvweigang{at}sklmg.edu.cn
Citation
DNA methylation detection is a significant biomarker for screening endometrial cancer in premenopausal women with abnormal uterine bleeding
Publication history
- Received May 11, 2024
- Accepted June 26, 2024
- First published July 23, 2024.
Article Versions
- You are currently viewing a Previous version of this article (23 July 2024).
- View the most recent version of this article
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© IGCS and ESGO 2024. No commercial re-use. See rights and permissions. Published by BMJ.